Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Practical Pointers: Clinically important drug-drug interactions and how to manage them
Journal of Primary Health Care, 06/16/09
Bryant L et al. - The more medicines a person requires, the increased risk of a drug–drug interaction. There are two types of medicine interactions—pharmacodynamic and pharmacokinetic...The A3 table included with this journal provides information on the management of some common medicine interactions. The potential for an interaction is often predictable, but there are usually many variables involved in whether the interaction will be clinically significant. Also not all medicines in the same class interact to the same extent, e.g. simvastatin versus atorvastatin.
Risk assessment:
- How common is the interaction?
- How severe will the interaction be if it occurs?
- Is it a dose-related interaction?
- Prescribe an alternative, non-interacting drug
- Stop the target interacting drug temporarily
- Monitor
- with investigations — INR, blood pressure, liver function tests
- clinically — dizziness, muscle aches
Today in Drug Interactions...keeping you current
Receive free subspecialty "5-minute updates" via email
A comparison of the acid-inhibitory effects of esomeprazole and pantoprazole in relation to pharmacokinetics and CYP2C19 polymorphism
Alimentary Pharmacology and Therapeutics, 12/10/09
Combination of intensive cognitive rehabilitation and donepezil therapy in Alzheimer's disease (AD)
Archives of Gerontology and Geriatrics, 12/09/09
Subcutaneous Sumatriptan Pharmacokinetics: Delimiting the Monoamine Oxidase Inhibitor Effect
Headache: The Journal of Head and Face Pain, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


